SCA
AGN

Spearhead Capital Advisors’s Allergan plc AGN Stock Holding History

Spearhead Capital Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,174
Closed -$1.36M – 75
2018
Q4 		$1.36M Sell
10,174
-9,157
-47% -$1.5M 0.58% 53
2018
Q3 		$3.67M Buy
19,331
+228
+1% +$41.9K 1.23% 30
2018
Q2 		$3.19M Buy
19,103
+1,289
+7% +$207K 1.14% 38
2018
Q1 		$3M Buy
17,814
+14,292
+406% +$2.4M 1.17% 46
2017
Q4 		$576K Buy
+3,522
New +$632K 0.28% 54

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Spearhead Capital Advisors's AGN Position: Q1 2019 in Review

Spearhead Capital Advisors sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 10,174 shares — an estimated $1.36M sold.

Spearhead Capital Advisors first reported a position in AGN in Q4 2017 and held it in 5 quarters. The position peaked at $3.67M in Q3 2018. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Spearhead Capital Advisors reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Spearhead Capital Advisors sold 10,174 Allergan plc shares in Q1 2019, an estimated $1.36M.
  • Spearhead Capital Advisors first reported a position in Allergan plc in Q4 2017 and held it in 5 quarters.
  • Spearhead Capital Advisors's Allergan plc position peaked at $3.67M in Q3 2018.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Spearhead Capital Advisors's 13F filing for Q1 2019, filed 23 Apr 2019.